Global Drug Delivery Devices Market Segmentation Analysis Report 2021-2026 | Global Drug Delivery Devices Industry Analysis on Size, Share, Growth, Trends, Demand, Competitive Analysis, and Forecast Report 2021-2026

Published: September 2020  |  Report ID:DRR12  | Pages: 150

Drug Delivery Devices Market Growth and Forecast (2021-2026):

Global Drug Delivery Devices Market size was worth USD 20 billion in 2021 and is anticipated to reach a value of USD 26 billion in 2026, developed at a CAGR of 4.3% between 2021 to 2026.

Drug Delivery Devices Market is segmented by Device Type into Smart Pills, Inhalers & Nebulizers, Drug Eluting Stents, Safety Syringes, Implantable Drug Delivery Device, and Transdermal Patches, Others, by End User into Hospitals and Diagnostic Centers, Ambulatory Surgery Centers and Clinics and Others

North America is the largest Market Share:

North America registered major drug delivery devices market share in 2018 due to growing adoption of drug delivery devices.

Growth in Asia Pacific Region:

According to our research analysis done by the Data Research Reports, Asia Pacific region is anticipated to grow at a highest Growth during the assessment year (2021-2026).

Recent Developments in Drug Delivery Devices Market:

S.No

Year

Recent Development/Acquisition/ Agreements/ Approval

1

In Mar 2019

Aptar Pharma received the U.S. FDA approval for nasal drug delivery device

2

In Dec 2019

YpsoMate autoinjector entered the Japanese market for accurate delivery of Teribone drug

Drug Delivery Devices Market Segmentation Analysis:

By Device Type:

  • Smart pills
  • Inhalers
  • Drug eluting stents
  • Safety syringes
  • Implantable drug delivery device
  • Transdermal patches
  • Others

By End User:

  • Hospitals & Diagnostic Centers
  • Ambulatory Surgical Centers & Clinics
  • Others

Drug Delivery Devices Market Geographical Analysis:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • United Kingdom
    • Spain
    • Germany
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia
    • Singapore
    • Malaysia
    • South Korea
    • New Zealand
    • Rest of APAC
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of LATAM
  • Middle East and Africa
    • Middle East
    • Africa

Key Players in the Market:

Major key Players in the Global Drug Delivery Devices Market are

  • 3M Company
  • AstraZeneca PLC
  • Becton, Dickinson And Company
  • Boehringer Ingelheim group
  • Consort Medical plc
  • GlaxoSmithKline plc
  • Insulet Corporation
  • Medtronic Plc.
  • Sulzer Ltd. (Medmix Systems AG)
  • West Pharmaceuticals Services, Inc
  1. Preface

1.1 Market Definition and Scope

1.2 Base Currency, Base Year and Forecast Periods

1.3 Key Research Objectives

1.4 Research Highlights

  1. General Study Assumptions
  2. Research Methodology

3.1 Introduction

3.2 Secondary Research

3.3 Primary Research

3.4 Analysis Design

3.5 Study Timeline

  1. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Market Trends

  1. Supply Chain Analysis
  2. Company Strategy Analysis

6.1 Merger and Acquisition Analysis

6.2 Agreements, Collaborations and Joint Ventures

6.3 Regional Presence

6.4 New Product Launches

  1. Market Outlook

7.1 Technological Advancement

7.2 Pricing Analysis

7.3 Epidemiology

7.4 Product Landscape Analysis (Brand Tracking Analysis & Pipeline Analysis)

  1. Market Segmentation

8.1 Overview

8.2 Drug Delivery Devices Market, By Device Type, forecast year 2021-2026

8.2.1 Smart pills

8.2.2 Inhalers

8.2.3 Drug eluting stents

8.2.4 Safety syringes

8.2.5 Implantable drug delivery device

8.2.6 Transdermal patches

8.2.7 Others

8.2.8 Market Size Estimations & Forecasts (2021-2026)

8.2.9 Y-o-Y Growth Analysis

8.2.10 Market Investment Opportunities Analysis

8.3 Drug Delivery Devices Market, By End User, forecast year 2021-2026

8.3.1 Hospitals & Diagnostic Centers

8.3.2 Ambulatory Surgical Centers & Clinics

8.3.2 Others

8.3.3 Market Size Estimations & Forecasts (2021-2026)

8.3.4 Y-o-Y Growth Analysis

8.3.5 Market Investment Opportunities Analysis

  1. Global Market Regional and Country Analysis, Forecast 2021-2026

9.1 Overview

9.2 Regional Trends

9.3 Impact Analysis

9.4 Key Findings

9.5 Drug Delivery Devices Market,  by Region, 2021-2026

9.5.1 By Device Type

9.5.2 By End User

  1. Competitive Landscape Analysis

10.1 Market Player

10.1.1 Company Revenue

10.1.2 Business unit

10.1.3 Product Mapping

10.1.4 Geographical Locations

10.2 Company Share Analysis

  1. Strategic Analysis

11.1 PESTLE analysis

11.2 Porter’s Five analysis

11.2.1 Bargaining Power of Suppliers

11.2.2 Bargaining Power of Consumers

11.2.3 Threat of New Entrants

11.2.4 Threat of Substitute Products and Services

11.2.5 Competitive Rivalry within the Industry

  1. Company Profiles

12.1 3M Company

12.1.1 Overview

12.1.2 Product Portfolio

12.1.3 Financial Details

12.1.4 SWOT Analysis

12.1.5 Market Strategies

12.2 AstraZeneca PLC

12.3 Becton, Dickinson And Company

12.4 Boehringer Ingelheim group

12.5 Consort Medical plc

12.6 GlaxoSmithKline plc

12.7 Insulet Corporation

12.8 Medtronic Plc

12.9 Sulzer Ltd. (Medmix Systems AG)

12.10 West Pharmaceuticals Services, Inc

  1. Market Guidance
  2. Appendix